Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.
NCT ID: NCT00802269
Last Updated: 2024-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
25 participants
INTERVENTIONAL
2008-03-31
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters
NCT01023698
Safety and Efficacy of Low-Fluence PRP for PDR
NCT01737957
PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System
NCT02645383
Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
NCT00563043
Panretinal Photocoagulation for Diabetic Retinopathy With PASCAL Laser
NCT01304225
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reduced Fluence Parameters
Eyes receiving retinal photocoagulation with reduced fluence parameters (time 20-50 msec, power 400-700 mW)
Retinal laser photocoagulation
Retinal laser photocoagulation using a 532 nm laser
Traditional parameters
Eyes receiving retinal photocoagulation with traditional parameters (time 100-200 msec, power 200-400 mW)
Retinal laser photocoagulation
Retinal laser photocoagulation using a 532 nm laser
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Retinal laser photocoagulation
Retinal laser photocoagulation using a 532 nm laser
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Proliferative diabetic retinopathy with indication for panretinal photocoagulation
Exclusion Criteria
* Previous ocular surgical procedures
* Ocular media opacities
* History of trigeminal neuralgia
* Chronic ocular pain
* Depression under conductual or medical treatment
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asociación para Evitar la Ceguera en México
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oscar Alvarez-Verduzco, MD
Role: PRINCIPAL_INVESTIGATOR
Asociación para Evitar la Ceguera en México
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asociacion para Evitar la Ceguera en Mexico
Mexico City, Mexico City, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APEC-032
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.